| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Veterinary Physiology and Pharmacology (R.D., W.P., I.S., S.S.) and Department of Biochemistry and Biophysics (C.V., M.K.) Texas A&M University College Station, Texas 77843
17ß-Estradiol (E2)
induced c-fos protooncogene mRNA levels in MCF-7 human
breast cancer cells, and maximal induction was observed within 1 h
after treatment. 2,3,7,8-Tetrachlorodibenzo-p-dioxin
(TCDD) inhibited the E2-induced response within
2 h. The molecular mechanism of this response was further
investigated using pFC2-CAT, a construct containing a -1400 to +41
sequence from the human c-fos protooncogene linked to a
bacterial chloramphenicol acetyltransferase (CAT) reporter gene. In
MCF-7 cells transiently transfected with pFC2-CAT, 10
nM E2 induced an
8.5-fold increase of CAT activity, and cotreatment with 10
nM TCDD decreased this response by more than
45%.
-Naphthoflavone, an aryl hydrocarbon receptor (AhR)
antagonist, blocked the inhibitory effects of TCDD; moreover, the
inhibitory response was not observed in variant Ah-nonresponsive MCF-7
cells, suggesting that the AhR complex was required for estrogen
receptor cross-talk. The E2-responsive sequence
(-1220 to -1155) in the c-fos gene promoter contains two
putative core pentanucleotide dioxin-responsive elements (DREs) at
-1206 to -1202 and -1163 to -1159. In transient transfection assays
using wild-type and core DRE mutant constructs, the downstream core DRE
(at -1163 to -1159) was identified as a functional inhibitory DRE.
The results of photo-induced cross-linking, gel mobility shift, and
in vitro DNA footprinting assays showed that the AhR
complex interacted with the core DRE that also overlapped the
E2-responsive GC-rich site (-1168 to -1161),
suggesting that the mechanism for AhR-mediated inhibitory effects may
be due to quenching or masking at the Sp1-binding site.
This article has been cited by other articles:
![]() |
B. P. Lawrence, M. S. Denison, H. Novak, B. A. Vorderstrasse, N. Harrer, W. Neruda, C. Reichel, and M. Woisetschlager Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound Blood, August 15, 2008; 112(4): 1158 - 1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Boverhof, L. D. Burgoon, K. J. Williams, and T. R. Zacharewski Inhibition of Estrogen-Mediated Uterine Gene Expression Responses by Dioxin Mol. Pharmacol., January 1, 2008; 73(1): 82 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. D. Moffat, P. C. Boutros, T. Celius, J. Linden, R. Pohjanvirta, and A. B. Okey microRNAs in Adult Rodent Liver Are Refractory to Dioxin Treatment Toxicol. Sci., October 1, 2007; 99(2): 470 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Ovando, C. M. Vezina, B. P. McGarrigle, and J. R. Olson Hepatic Gene Downregulation following Acute and Subchronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicol. Sci., December 1, 2006; 94(2): 428 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khan, R. Barhoumi, R. Burghardt, S. Liu, K. Kim, and S. Safe Molecular Mechanism of Inhibitory Aryl Hydrocarbon Receptor--Estrogen Receptor/Sp1 Cross Talk in Breast Cancer Cells Mol. Endocrinol., September 1, 2006; 20(9): 2199 - 2214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Hockings, P. A. Thorne, M. Q. Kemp, S. S. Morgan, O. Selmin, and D. F. Romagnolo The Ligand Status of the Aromatic Hydrocarbon Receptor Modulates Transcriptional Activation of BRCA-1 Promoter by Estrogen Cancer Res., February 15, 2006; 66(4): 2224 - 2232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Matthews, B. Wihlen, J. Thomsen, and J.-A. Gustafsson Aryl Hydrocarbon Receptor-Mediated Transcription: Ligand-Dependent Recruitment of Estrogen Receptor {alpha} to 2,3,7,8-Tetrachlorodibenzo- p-Dioxin-Responsive Promoters Mol. Cell. Biol., July 1, 2005; 25(13): 5317 - 5328. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Pocar, B Fischer, T Klonisch, and S Hombach-Klonisch Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction Reproduction, April 1, 2005; 129(4): 379 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. V. Sun, D. R. Boverhof, L. D. Burgoon, M. R. Fielden, and T. R. Zacharewski Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences Nucleic Acids Res., August 24, 2004; 32(15): 4512 - 4523. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Petz, Y. S. Ziegler, J. R. Schultz, and A. M. Nardulli Fos and Jun Inhibit Estrogen-Induced Transcription of the Human Progesterone Receptor Gene through an Activator Protein-1 Site Mol. Endocrinol., March 1, 2004; 18(3): 521 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brunnberg, K. Pettersson, E. Rydin, J. Matthews, A. Hanberg, and I. Pongratz The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription PNAS, May 27, 2003; 100(11): 6517 - 6522. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kim, N. Thu, B. Saville, and S. Safe Domains of Estrogen Receptor {alpha} (ER{alpha}) Required for ER{alpha}/Sp1-Mediated Activation of GC-Rich Promoters by Estrogens and Antiestrogens in Breast Cancer Cells Mol. Endocrinol., May 1, 2003; 17(5): 804 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wormke, M. Stoner, B. Saville, K. Walker, M. Abdelrahim, R. Burghardt, and S. Safe The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor {alpha} through Activation of Proteasomes Mol. Cell. Biol., March 15, 2003; 23(6): 1843 - 1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bhathena, C. Lee, and D. S. Riddick Suppression of Cytochrome P450 2C11 by Aromatic Hydrocarbons: Mechanistic Insights from Studies of the 5'-Flanking Region of the CYP2C11 Gene Drug Metab. Dispos., December 1, 2002; 30(12): 1385 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Min, H. Kim, Y. Bae, L. Petz, and J. K. Kemper Inhibitory Cross-talk between Estrogen Receptor (ER) and Constitutively Activated Androstane Receptor (CAR). CAR INHIBITS ER-MEDIATED SIGNALING PATHWAY BY SQUELCHING p160 COACTIVATORS J. Biol. Chem., September 6, 2002; 277(37): 34626 - 34633. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Rogers and M. S. Denison Analysis of the Antiestrogenic Activity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Human Ovarian Carcinoma BG-1 Cells Mol. Pharmacol., June 1, 2002; 61(6): 1393 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Dimitrova, K. DeGroot, A. K Myers, and Y. D Kim Estrogen and homocysteine Cardiovasc Res, February 15, 2002; 53(3): 577 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson Mechanisms of Estrogen Action Physiol Rev, October 1, 2001; 81(4): 1535 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. McDougal, M. Wormke, J. Calvin, and S. Safe Tamoxifen-induced Antitumorigenic/Antiestrogenic Action Synergized by a Selective Aryl Hydrocarbon Receptor Modulator Cancer Res., May 1, 2001; 61(10): 3902 - 3907. [Abstract] [Full Text] |
||||
![]() |
I. Samudio, C. Vyhlidal, F. Wang, M. Stoner, I. Chen, M. Kladde, R. Barhoumi, R. Burghardt, and S. Safe Transcriptional Activation of Deoxyribonucleic Acid Polymerase {{alpha}} Gene Expression in MCF-7 Cells by 17{{beta}}-Estradiol Endocrinology, March 1, 2001; 142(3): 1000 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Fertuck, J. B. Matthews, and T. R. Zacharewski Hydroxylated Benzo[a]pyrene Metabolites Are Responsible for in Vitro Estrogen Receptor-Mediated Gene Expression Induced by Benzo[a]pyrene, but Do Not Elicit Uterotrophic Effects in Vivo Toxicol. Sci., February 1, 2001; 59(2): 231 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Buchanan, T. Sato, R. E. Peterson, and P. S. Cooke Antiestrogenic Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Mouse Uterus: Critical Role of the Aryl Hydrocarbon Receptor in Stromal Tissue Toxicol. Sci., October 1, 2000; 57(2): 302 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stoner, F. Wang, M. Wormke, T. Nguyen, I. Samudio, C. Vyhlidal, D. Marme, G. Finkenzeller, and S. Safe Inhibition of Vascular Endothelial Growth Factor Expression in HEC1A Endometrial Cancer Cells through Interactions of Estrogen Receptor alpha and Sp3 Proteins J. Biol. Chem., July 21, 2000; 275(30): 22769 - 22779. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |